What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are creating a new class of medicines.
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
… Axiomer Investor Call ProQR management will host an investor … conference call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the … the presentation date. Download the presentation About Axiomer ® ProQR is pioneering a next-generation RNA editing …
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
… Analyst & Investor Axiomer® technology R&D Event This virtual event on March 29, … by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the …
… ProQR at TIDES to highlight our Axiomer® technology This month several ProQRians will attend … Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology. This month several …
… Axiomer Technology - Therapeutic oligonucleotides for … site-specific A-to-I editing by endogenous ADAR enzymes Axiomer® platform applicability and potential in …
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
